Prevalence rate of Hepatitis B and Hepatitis C on the 271 patients tested positive with Hepatocellular Carcinoma among 396 patients living with Decompensated Cirrhosis recorded at the Bertoua Regional Hospital in Est Region Cameroon
- Author(s): Olivier Lieuga a ,Tatiana Jiengoué a,a,, and Augustine Nji Asakizi a
- Institution: School of Health and Biomedical Sciences, Kesmonds International University of America
PAPER DETAILS
- Paper ID:Paper ID: 26005013
- Volume :IQRJ V05I02
- Issue:02
- May 2026
- ISSN: 2790-4296(Online)
- ISBN: 978-9956-504-74-9(Print)
Olivier Lieuga
Email:
olivierlieuga@kesmondsuniversity.org
Olivier Lieuga ,Tatiana Jiengoué,, and Augustine Nji Asakizi. (2026). Prevalence rate of Hepatitis B and Hepatitis C on the 271 patients tested positive with Hepatocellular Carcinoma among 396 patients living with Decompensated Cirrhosis recorded at the Bertoua Regional Hospital in Est Region Cameroon. IQ Research Journal, 5(2), IQRJ-V05I02-26005013
ABSTRACT
Introduction:
Hepatocellular Carcinoma (HCC) factors are dominated by chronic liver inflammation, with 80 90% of cases arising from cirrhosis. The primary drivers are chronic infections (Hepatitis B/C), alcohol abuse and metabolic dysfunction associated steatosis li ver disease (MASLD formerly NAFLD). Other key factors include smoking, obesity, type 2 diabetes and exposure to aflatoxins.
Methods:
It is descriptive cross sectional study done on 271 patients (187 men and 84 women) tested positive with HCC among 396 p atients living with decompensated cirrhosis recorded at the Intensive Care Unit of Bertoua Regional Hospital from June to October 2025 after receiving ethical clearance and Research Authorization from Est Public Health Delegation Cameroon. Convenience sa mpling was done. The analysis included major risk factors of HCC such HBV, HCV, Alcohol Toxic, Traditional Drugs Toxic, Aflatoxins and NAFLD.
Results:
Out to 396 Cirrhosis patients, the prevalence rate of HCC was 68,43% and among 271 HCC patients, the prev alence rate of HBV for men is estimated at 41,69% and for women was 37,63%, followed by HCV (23,24% for men and 31,99% for women).
Conclusions:
This study showed that the prevalence of Hepatitis B and C among patients living with hepatocellular carcinom a was high when compared to similar studies conducted in similar settings.